Risk of myocardial infarction related to factor V Leiden mutation: a meta-analysis
Moataz Dowaidar1, Ahmad Settin
1Genetics Unit, Egypt and Research Center, College of Medicine, Qassim University, Mansoura University Children Hospital, Buraydah, Saudi Arabia.
Background:
Myocardial infarction (MI) can be due to inherited thrombophilia caused by resistance to activated protein C resulting from factor V Leiden (FVL) mutation.
Objectives:
The objectives of this study were to estimate the frequency of FVL mutation among MI cases in various populations and calculate the overall risk related to it.
Subjects And Methods:
Subjects comprised 7790 cases with MI and 19,276 healthy controls collected from 41 relevant studies in the search databases. The resulting frequency of FVL mutation among cases and the odds ratio were compared and integrated in a meta-analysis format.
Results:
Although there was marked variation of the frequency of FVL mutation among different populations including MI and healthy controls, most studies reported a positive risk related to it. Compilation of analyzed studies resulted in an overall frequency of FVL mutation of 6.791% among MI cases, which was significantly higher than that among controls (1.304%, p = 0.0) with an overall odds ratio of 1.608 (95% confidence interval, 1.98-4.44).
Conclusion:
There is a definite risk related to the carriage of FVL mutation among MI cases. This should have a potential impact on the genetic counseling of family members of affected cases for proper prophylaxis.
Insights
The factor V Leiden (FVL) mutation increases the risk of myocardial infarction (MI). This genetic factor is more frequent in MI patients than in healthy individuals, highlighting its clinical significance.
Area of Science:
- Cardiovascular Genetics
- Thrombophilia Research
- Molecular Epidemiology
Background:
- Myocardial infarction (MI) is linked to inherited thrombophilia, specifically resistance to activated protein C due to the factor V Leiden (FVL) mutation.
- Understanding the prevalence and risk associated with FVL mutation in MI is crucial for cardiovascular disease research.
Purpose of the Study:
- To determine the frequency of the FVL mutation in myocardial infarction (MI) cases across diverse populations.
- To quantify the overall risk of MI associated with carrying the FVL mutation.
Main Methods:
- A meta-analysis was conducted on data from 41 studies.
- Included were 7,790 MI cases and 19,276 healthy controls.
- Frequencies and odds ratios for FVL mutation were compared between groups.
Main Results:
- The FVL mutation was found in 6.791% of MI cases versus 1.304% of controls.
- An overall odds ratio of 1.608 (95% CI: 1.98-4.44) indicated a significantly increased risk of MI associated with FVL mutation.
- Significant variations in FVL mutation frequency were observed among different populations.
Conclusions:
- Carriage of the factor V Leiden mutation presents a definitive risk for myocardial infarction.
- Findings have implications for genetic counseling and prophylactic strategies for families of MI patients.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Relative Risk
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
